Name: Finasteride Tablets (Qianolin® / Xiangjiang) 5?mg ×?60 Tablets - Arizona-mall
Price: 1.00 HKD
Availability: InStock

Finasteride Tablets (Qianolin® / Xiangjiang) 5?mg ×?60 Tablets

$1.00

Finasteride is a selective 5?-reductase inhibitor that prevents testosterone from converting to dihydrotestosterone (DHT), widely used in biomedical research on androgenic alopecia and benign prostatic hyperplasia (BPH). This product offers 5?mg tablets in a 60-count bottle from Hunan Qianjin Xiangjiang Pharmaceutical. Strictly for laboratory or preclinical research use only—not for therapeutic, clinical, diagnostic, or veterinary application.?Please consult staff for other specifications and uses?

Compare

描述

Contents hide

1 Product Specifications

2 Mechanism of Action

3 Research Applications & Pharmacology

4 Safety Profile & Handling

Product Specifications

Attribute	Details
Product Name	Finasteride Tablets (Qianolin® / Xiangjiang)
Generic Name	Finasteride
CAS Number	98319?26?7 (zh.wikipedia.org)
Molecular Formula	C??H??N?O?
Molecular Weight	~372.5?g/mol (free base)
Dosage Form	Film-coated oral tablet
Strength	5?mg per tablet
Pack Size	60 tablets per bottle
Approval No.	China NMPA H20040333
Product Code	86904960000424
Manufacturer	Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
Barcode	6934805201703
Storage Conditions	Store at 15–25?°C; keep dry and away from light
Intended Use	Laboratory/preclinical research only

Mechanism of Action

Finasteride is a competitive inhibitor of Type II (and III) 5?-reductase, blocking the conversion of testosterone to DHT and reducing serum and tissue levels of DHT by approximately 70%–90% . This enzyme blockade is central to androgenic alopecia and BPH models.

Research Applications & Pharmacology

Androgenic Alopecia Studies: Suppresses follicular DHT, slowing hair loss and promoting regrowth .
Benign Prostatic Hyperplasia (BPH) Models: Reduces prostate volume, urinary retention, and delays surgical intervention.
Pharmacokinetics: ~90% protein bound, bioavailability ~65%, half-life ~5–6?hours in adults (longer in elderly); metabolized by liver (CYP3A4), excreted in feces (57%) & urine (40%) .
Comparative 5-ARI Research: Finasteride inhibits Type II, leading to ~70% DHT reduction, vs. dutasteride (~95%) .

Safety Profile & Handling

Common Adverse Effects (in vivo): Rare sexual dysfunction, decreased libido, ejaculation disorders .
Serious Risks: Potential depression, self-harm (in elderly), gynecomastia (~1.3%) .
Contraindications: Not for use by females, especially pregnant, due to teratogenic DHT suppression.
Handling Advice: Store under recommended temperature; use PPE when opening; discard per lab biosafety guidelines.

其他信息

重量	1.1 公斤
尺寸	18 × 16 × 18 厘米

评价

目前还没有评价

成为第一个“Finasteride Tablets (Qianolin® / Xiangjiang) 5?mg ×?60 Tablets” 的评价者